CHEBI:135521 - captodiame

ChEBI IDCHEBI:135521
ChEBI Namecaptodiame
Stars
Last Modified23 February 2017
DownloadsMolfile
FormulaC21H29NS2
Net Charge0
Average Mass359.604
Monoisotopic Mass359.17414
SMILESCCCCSc1ccc(C(SCCN(C)C)c2ccccc2)cc1
InChIInChI=1S/C21H29NS2/c1-4-5-16-23-20-13-11-19(12-14-20)21(24-17-15-22(2)3)18-9-7-6-8-10-18/h6-14,21H,4-5,15-17H2,1-3H3
InChIKeyIZLPZXSZLLELBJ-UHFFFAOYSA-N
Roles Classification
Application:
anxiolytic drug  Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.
ChEBI Ontology
Outgoing Relation(s)
captodiame (CHEBI:135521) has role anxiolytic drug (CHEBI:35474)
captodiame (CHEBI:135521) is a diarylmethane (CHEBI:51614)
captodiame (CHEBI:135521) is a organic molecular entity (CHEBI:50860)
captodiame (CHEBI:135521) is a racemate (CHEBI:60911)
INN  Source
captodiamoWHO MedNet
Synonyms  Source
captodiamDrugCentral
CaptodiameChEMBL
captodiaminDrugCentral
captodiamineDrugCentral
captodiamine HClDrugCentral
captodiamine hydrochlorideDrugCentral
Manual XrefsDatabases
483DrugCentral
Registry NumbersSources
CAS:486-17-9DrugCentral